 |
|
TargeGen, Inc., formed in 2001, is a privately held biopharmaceutical company based in San Diego, CA. The company develops small molecule kinase inhibitors for the treatment of hematological malignancies and certain other disorders.
|
| ::Read
More |
|
 |
 |
 |
October 22nd
TargeGen Announces Successful Completion of Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients
|
| ::Read More |
|
 |
|
For more information, please see
www.clinicaltrials.gov |
| ::Read More |
|
